Ronald J. Voll

1.7k citations

84 papers · 1.4k indexed · h-index 21

Molecular Biology
Cellular and Molecular Neuroscience top 5%
Radiology, Nuclear Medicine and Imaging top 5%
Organic Chemistry top 10%
Oncology

Co-authors: Mark M. Goodman Ezzat S. Younathan John R. Votaw Theodore A.W. Koerner Jeffrey S. Stehouwer Nachwa Jarkas Larry Williams Jonathan McConathy
Topics: Medical Imaging Techniques and Applications (20 papers)Neuroscience and Neuropharmacology Research (20 papers)Neurotransmitter Receptor Influence on Behavior (17 papers)
Cited by: Cellular and Molecular Neuroscience Biological Psychiatry Pharmaceutical Science
Journals: Journal of Biological Chemistry Nature Communications PLoS ONE
Partner nations: United States Bangladesh France

In The Last Decade

Ronald J. Voll

82 papers receiving 1.4k citations

Peers

Countries citing papers authored by Ronald J. Voll

Since Specialization

Citations

This map shows the geographic impact of Ronald J. Voll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald J. Voll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald J. Voll more than expected).

Fields of papers citing papers by Ronald J. Voll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald J. Voll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald J. Voll. The network helps show where Ronald J. Voll may publish in the future.

Co-authorship network of co-authors of Ronald J. Voll

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald J. Voll. A scholar is included among the top collaborators of Ronald J. Voll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald J. Voll. Ronald J. Voll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis, radiolabeling, and biological evaluation of methyl 6-deoxy-6-[¹⁸F]fluoro-4-thio-α-d-maltotrioside as a positron emission tomography bacterial imaging agent 2025 ·RSC Advances ·Kiyoko Takemiya,(unknown),Ronald J. Voll,Sheng Zhao,Giji Joseph,Shelly Wang,Fanxing Zeng,Jonathon A. Nye,Niren Murthy,W. Robert Taylor,Mark M. Goodman	1
2	PET imaging of dopamine transporters and D2/D3 receptors in female monkeys: effects of chronic cocaine self-administration 2023 ·Neuropsychopharmacology ·(unknown),Angela N. Duke,Susan H. Nader,Adrienne L. Adler-Neal,Kiran Kumar Solingapuram Sai,Beth A. Reboussin,H. Donald Gage,Ronald J. Voll,Akiva Mintz,Mark M. Goodman,Michael A. Nader	10
3	Synthesis, Radiolabeling, and Biological Evaluation of the trans-Stereoisomers of 1-Amino-3-(fluoro-¹⁸F)-4-fluorocyclopentane-1-carboxylic Acid as PET Imaging Agents 2021 ·ACS Pharmacology & Translational Science ·Thomas C. Pickel,(unknown),Ronald J. Voll,Weiping Yu,Zhaobin Zhang,Jonathon A. Nye,John Bacsa,Jeffrey J. Olson,Lanny S. Liebeskind,Mark M. Goodman	5
4	A Swine Hind Limb Ischemia Model Useful for Testing Peripheral Artery Disease Therapeutics 2021 ·Journal of Cardiovascular Translational Research ·(unknown),(unknown),(unknown),Lanfang Wang,Ronald J. Voll,Steven H. Liang,Mark M. Goodman,John N. Oshinski,Rebecca D. Levit	7
5	Re(CO) 3 ([ 18 F]FEDA), a novel 18 F PET renal tracer: Radiosynthesis and preclinical evaluation 2017 ·Nuclear Medicine and Biology ·Małgorzata Lipowska,(unknown),Ronald J. Voll,Jonathon A. Nye,(unknown),Mark M. Goodman,Andrew Taylor	12
6	Synthesis, binding affinity, radiolabeling, and microPET evaluation of 4-(2-substituted-4-substituted)-8-(dialkylamino)-6-methyl-1-substituted-3,4-dihydropyrido[2,3-b]pyrazin-2(1H)-ones as ligands for brain corticotropin-releasing factor type-1 (CRF1) receptors 2015 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey S. Stehouwer,Chase H. Bourke,Michael J. Owens,Ronald J. Voll,Clinton D. Kilts,Mark M. Goodman	5
7	Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor 2015 ·Bioorganic & Medicinal Chemistry ·Jeffrey S. Stehouwer,(unknown),Ronald J. Voll,Michael J. Owens,(unknown),Chase H. Bourke,(unknown),Clinton D. Kilts,Mark M. Goodman	6
8	Quantification of dopamine transporter density with [18F]FECNT PET in healthy humans 2014 ·Nuclear Medicine and Biology ·Jonathon A. Nye,John R. Votaw,J. Douglas Bremner,Margaret R. Davis,Ronald J. Voll,Vernon M. Camp,Mark M. Goodman	11
9	DECREASED BRAINSTEM AND PUTAMEN SERT BINDING POTENTIAL IN DEPRESSED SUICIDE ATTEMPTERS USING [¹¹C]-ZIENT PET IMAGING 2013 ·Depression and Anxiety ·Jonathon A. Nye,David Purselle,Christophe Plisson,Ronald J. Voll,Jeffrey S. Stehouwer,John R. Votaw,Clinton D. Kilts,Mark M. Goodman,Charles B. Nemeroff	38
10	Carbon-11 N-methyl alkylation of L-368,899 and in vivo PET imaging investigations for neural oxytocin receptors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Aaron L. Smith,Sara M. Freeman,Ronald J. Voll,Larry J. Young,Mark M. Goodman	19
11	Biodistribution and human dosimetry of enantiomer-1 of the synthetic leucine analog anti-1-amino-2-fluorocyclopentyl-1-carboxylic acid 2011 ·Nuclear Medicine and Biology ·Jonathon A. Nye,(unknown),David M. Schuster,Bital Savir-Baruch,Ronald J. Voll,Vernon M. Camp,Mark M. Goodman	2
12	Characterization of the two enantiomers of anti-18F-FACPC as PET tumor agents 2010 ·Nature Communications ·Nachwa Jarkas,Ronald J. Voll,Vernon M. Camp,Zhaobin Zhang,Mark M. Goodman	4
13	18F-FECNT: Validation as PET dopamine transporter ligand in parkinsonism 2010 ·Experimental Neurology ·Gunasingh Masilamoni,John R. Votaw,Leonard L. Howell,Rosa M. Villalba,Mark M. Goodman,Ronald J. Voll,Jeffrey S. Stehouwer,Thomas Wichmann,Yoland Smith	37
14	Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter 2007 ·Bioorganic & Medicinal Chemistry ·Fanxing Zeng,Nachwa Jarkas,Jeffrey S. Stehouwer,Ronald J. Voll,Michael J. Owens,Clinton D. Kilts,Charles B. Nemeroff,Mark M. Goodman	13
15	Synthesis and biological evaluation of 2β,3α-(substituted phenyl)nortropanes as potential norepinephrine transporter imaging agents 2007 ·Bioorganic & Medicinal Chemistry Letters ·Fanxing Zeng,Jeffrey S. Stehouwer,Nachwa Jarkas,Ronald J. Voll,Larry Williams,Vernon M. Camp,John R. Votaw,Michael J. Owens,Clinton D. Kilts,Charles B. Nemeroff,Mark M. Goodman	3
16	Synthesis and evaluation of two 18F-labeled imidazo[1,2-a]pyridine analogues as potential agents for imaging β-amyloid in Alzheimer’s disease 2006 ·Bioorganic & Medicinal Chemistry Letters ·Fanxing Zeng,(unknown),Ronald J. Voll,John R. Votaw,Larry Williams,Brian J. Ciliax,Allan I. Levey,Mark M. Goodman	42
17	Semi-automated preparation of the dopamine transporter ligand [18F]FECNT for human PET imaging studies 2005 ·Applied Radiation and Isotopes ·Ronald J. Voll,Jonathan McConathy,(unknown),Ronald J. Crowe,Mark M. Goodman	14
18	Improved synthesis of anti-[18F]FACBC: improved preparation of labeling precursor and automated radiosynthesis 2003 ·Applied Radiation and Isotopes ·Jonathan McConathy,Ronald J. Voll,Weiping Yu,Ronald J. Crowe,Mark M. Goodman	74
19	Structure of 2,5:3,4-dianhydro-D-altritol 1992 ·Acta Crystallographica Section C Crystal Structure Communications ·(unknown),Ronald J. Voll,Frank R. Fronczek,Ezzat S. Younathan	2
20	The x-ray crystal structure of 2,3:4,5-di-O-isopropylidene-1-O-methyl-β-d-fructopyranose 1990 ·Carbohydrate Research ·Steven F. Watkins,(unknown),Frank R. Fronczek,Ronald J. Voll,Ezzat S. Younathan	4

About Ronald J. Voll

Ronald J. Voll is a scholar working on Biological Psychiatry, Behavioral Neuroscience and Cellular and Molecular Neuroscience, having authored 84 papers that have together received 1.4k indexed citations. Recurring topics across this work include Medical Imaging Techniques and Applications (20 papers), Neuroscience and Neuropharmacology Research (20 papers) and Neurotransmitter Receptor Influence on Behavior (17 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (335 citations), Biological Psychiatry (44 citations) and Pharmaceutical Science (105 citations). Ronald J. Voll has collaborated with scholars based in United States, Bangladesh and France. Frequent co-authors include Mark M. Goodman, Ezzat S. Younathan, John R. Votaw, Theodore A.W. Koerner, Jeffrey S. Stehouwer, Nachwa Jarkas, Larry Williams, Jonathan McConathy, S. P. McGlynn and Dan Dougherty. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact